Prognostic factors in localized renal cell cancer

BJU International

Volumn 99, Issue 5 B, 2007, Pages 1212-1216

  Knight, David A ^a   Stadler, Walter M ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Risk groups; Staging system; Survival; Tumour subtypes

Indexed keywords

CANCER LOCALIZATION; HUMAN; KIDNEY CARCINOMA; LABORATORY TEST; METASTASIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEOPLASM STAGING; PROGNOSIS;

EID: 34247264461     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06813.x     Document Type: Review

References (30)

1. Lane BR, Kattan MW. Predicting outcomes in renal cell carcinoma. Current Opin Urol 2005; 15: 289-97
2. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611-23
3. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 2005; 173: 1889-92
4. Ficarra V, Martignoni G, Lohse C et al. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol 2006; 175: 1235-9
5. Javidan J, Stricker HJ, Tamboli P et al. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol 1999; 162: 1277-81
6. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 2000; 89: 604-14
7. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS. Renal Cell Carcinoma 2005: new frontiers in staging prognostication and targeted molecular therapy. J Urol 2005; 173: 1853-62
8. Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000; 163: 1090-5
9. Kinouchi T, Saiki S, Meguro N et al. Impact of tumor size on the clinical outcomes of patients with Robson stage I renal cell carcinoma. Cancer 1999; 85: 689-95
10. Ficarra V, Guille F, Schips L et al. Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 2005; 104: 2116-23
11. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003; 27: 612-24
12. Patard JJ, Leray E, Rioux-Leclercq N et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23: 2763-71
13. Nicol D, Hii SI, Walsh M et al. Vascular endothelial growth factor expression is increased in renal cell carcinoma. J Urol 1997; 157: 1482-6
14. Sorbellini M, Kattan MW, Snyder ME et al. A postoperative nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005; 173: 48-51
15. Delahunt B, Eble JN, McCredie M, Bethwaite PB, Stewart JH, Bilous AM. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001; 32: 590-4
16. Mejean A, Oudard S, Thiounn N. Prognostic factors of renal cell carcinoma. J Urol 2003; 169: 821-7
17. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002; 168: 2395-400
18. Chao D, Zisman A, Pantuck AJ et al. Collecting duct renal cell carcinoma: clinical study of a rare tumor. J Urol 2002; 167: 71-4
19. Kontak JA, Campbell SC. Prognostic factors in renal cell carcinoma. Urol Clin North Am 2003; 30: 467-80
20. Aubert S, Zini L, Delomez J, Biserte J, Lemaitre L, Leroy X. Cystic renal carcinomas in adults. Is preoperative recognition of multilocular cystic renal cell carcinoma possible? J Urol 2005; 174: 2115-9
21. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63
22. Leibovich BC, Cheville JC, Lohse CM. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 2005; 174: 1759-63
23. Zisman A, Pantuck AJ, Dorey F et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001; 19: 1649-57
24. O'Keefe SC, Marshall FF, Issa MM, Harmon MP, Petros JA. Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 2002; 168: 1378-80
25. Bensalah K, Leray E, Fergelot P et al. Prognostic value of thrombocytosis in renal cell carcinoma. J Urol 2006; 175: 859-63
26. Kim HL, Belldegrun AS, Freitas DG et al. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. J Urol 2003; 170: 1742-6
27. Zisman A, Pantuck AJ, Figlin RA, Belldegrun AS. Validation of the UCLA integrated staging system for patients with renal cell carcinoma. J Clin Oncol 2001; 19: 3792-3
28. Zisman A, Pantuck AJ, Weider J et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002; 20: 4559-66
29. Patard JJ, Kim HL, Lam JS et al. Use of the University of California Los Angeles Integrate Staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 2004; 22: 3316-22
30. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001; 166: 63-7